Ascentage Pharma Group International ADR - W/I (AAPGV.US) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Oct1

AAPGV.US released FY2023 Q2 earnings on October 1, 2024 (BJT) with actual revenue of 9.816 M USD and EPS of -0.1011 USD

15:00

AAPGV.US released FY2023 Semi-Annual Earnings on October 1, 2024 (BJT) with actual revenue of 20.19 M USD and EPS of -0.2079 USD

15:00

AAPGV.US released FY2024 Semi-Annual Earnings on October 1 (BJT), with actual revenue of 113.72 M USD and EPS of 0.0759 USD

15:00

AAPGV.US released FY2024 Q1 earnings on October 1, 2024 (BJT) with actual revenue of 57.04 M USD and EPS of 0.038 USD

15:00

AAPGV.US released FY2024 Q2 earnings on October 1 (BJT), with actual revenue of 56.67 M USD and EPS of 0.0378 USD

15:00

AAPGV.US released FY2023 Q1 earnings on October 1, 2024 (BJT) with actual revenue of 10.38 M USD and EPS of -0.1069 USD

15:00

Schedules & Filings

Schedules

Filings

Jan27

Ticker Change(EST)

From 01.27 changed to AAPG

Jan24

IPO(EST)

Listing Price USD 20.34

Oct1

Earning Release(EST)

FY2024 Q2 Earning Release (USD) Revenue 56.67 M, Net Income 11.21 M, EPS 0.0378

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More